P S Goedegebuure - JoVE Visualize

Showing results (41-50 of 45) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 45 results.

Surgical Oncology|April 1, 1994

Reactivation of murine tumour-infiltrating lymphocytes with solid-phase anti-CD3 antibody: in vitro cytokine production is associated with in vivo efficacyP S Goedegebuure, M Zuber, D L Leonard-Vidal, et al.

Surgery|January 16, 1999

Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligandW von Bernstorff, R A Spanjaard, A K Chan, et al.

Cancer Immunology, Immunotherapy : CII|July 1, 1993

Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapyJ Kan-Mitchell, X Q Huang, L Steinman, et al.

Surgery|June 8, 2001

Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinomaD C Lockhart, A K Chan, S Mak, et al.

Surgery|March 15, 2000

B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptorA K Chan, P S Goedegebuure, W von Bernstorff, et al.

Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 45 results.

Surgical Oncology|April 1, 1994

Reactivation of murine tumour-infiltrating lymphocytes with solid-phase anti-CD3 antibody: in vitro cytokine production is associated with in vivo efficacyP S Goedegebuure, M Zuber, D L Leonard-Vidal, et al.

Surgery|January 16, 1999

Pancreatic cancer cells can evade immune surveillance via nonfunctional Fas (APO-1/CD95) receptors and aberrant expression of functional Fas ligandW von Bernstorff, R A Spanjaard, A K Chan, et al.

Cancer Immunology, Immunotherapy : CII|July 1, 1993

Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapyJ Kan-Mitchell, X Q Huang, L Steinman, et al.

Surgery|June 8, 2001

Loss of T-cell receptor-CD3zeta and T-cell function in tumor-infiltrating lymphocytes but not in tumor-associated lymphocytes in ovarian carcinomaD C Lockhart, A K Chan, S Mak, et al.

Surgery|March 15, 2000

B7.1 costimulation increases T-cell proliferation and cytotoxicity via selective expansion of specific variable alpha and beta genes of the T-cell receptorA K Chan, P S Goedegebuure, W von Bernstorff, et al.

Pageof 5